ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

Li, D; March, ME; Gutierrez-Uzquiza, A; Kao, C; Seiler, C; Pinto, E; Matsuoka, LS; Battig, MR; Bhoj, EJ; Wenger, TL; Tian, LF; Robinson, N; Wang, TC; Liu, YC; Weinstein, BM; Swift, M; Jung, HM; Kaminski, CN; Chiavacci, R; Perkins, JA; Levine, MA; Sle

Hakonarson, H (reprint author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.; Hakonarson, H (reprint author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.; Hakonarson, H (reprint author), Childrens Hosp

NATURE MEDICINE, 2019; 25 (7): 1116

Abstract

The treatment of lymphatic anomaly, a rare devastating disease spectrum of mostly unknown etiologies, depends on the patient manifestations(1). Identi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索